Parkinson's disease (PD) is one of the most common neurodegenerative disorders and is
characterized by the loss of dopaminergic neurons in the substantia nigra (SN). Although the …

Parkinson disease (PD) is a neurodegenerative disease characterized by progressive
dopaminergic neurodegeneration in the substantia nigra pars compacta (SNc) area. The …

Parkinson's disease (PD) is a neurodegenerative disorder, caused by the selective death of
dopaminergic neurons in the substantia nigra pars compacta. β-caryophyllene (BCP) is a …

Background Neuroprotection with cannabinoids in Parkinson's disease (PD) has been
afforded predominantly with antioxidant or anti-inflammatory cannabinoids. In the present …

Parkinson's disease (PD) is one of the most common neurodegenerative diseases resulting
from the continuous death of dopaminergic neurons in substantia nigra. MPP+ (1-methyl-4 …

The cannabinoid type two receptors (CB2), an important component of the endocannabinoid
system, have recently emerged as neuromodulators and therapeutic targets for …

The pathological alterations of Parkinson's disease (PD) predominantly manifest as a loss of
dopaminergic neurons in the substantia nigra, which may be caused by oxidative stress …

1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) causes the damage of dopaminergic
neurons as seen in Parkinson's disease (PD). Oxidative stress has been implicated in the …

In the present study, we investigated the neuroprotective effects of echinacoside, a
phenylethanoid glycoside extracted from the medicinal Chinese herb Cistanches salsa …

Background/Aims: The activation of cannabinoid receptor 2 (CB2) has the beneficial effect of
reducing neuroinflammatory response in the treatment of Alzheimer's disease (AD) and is …